General MetAP2
publication:
Physiological mechanisms of sustained fumagillin-induced weight loss JCI Insight, March 2018
poster:
Weight Loss and Improved Safety Profile: Preclinical Studies with the MetAP2 Inhibitor, ZGN-1061 The Obesity Society, November 2017, Poster T-P-LB-3596
poster:
MetAP2 inhibitor treatment acutely reduces ERK phosphorylation and modulates expression of ERK responsive hepatic lipid metabolism genes in obese C57BL/6 mice Obesity Society Annual Meeting, October 2011, Poster 63-LB-P
poster:
ZGN-201, a MetAP2 Inhibitor, Reduces Body Weight and Normalizes Glucose Tolerance in Overweight Dogs Obesity Society Annual Meeting, October 2010, Poster 763
poster:
ZGN-201, a Methionine Aminopeptidase 2 Inhibitor, Durably Eliminates Excess Body Fat in Obese Mice through Regulation of Fat Metabolism and Food Intake American Diabetes Association Annual Meeting, June 2010, Poster 1803
